SEARCH

SEARCH BY CITATION

References

  • 1
    OrlicD, KajsturaJ, ChimentiS, JakoniukI, AndersonSM, LiBaosheng, PickelJ, McKayR, Nadal-GinardB, BodineDM, et al . Bone marrow cells regenerate infarcted myocardium. Nature . 2001: 410; 701705.
  • 2
    BearziC, RotaM, HosodaT, TillmannsJ, NascimbeneA, De AngelisA, Yasuzawa-AmanoS, TrofimovaI, SigginsRW, LecapitaineN, et al . Human cardiac stem cells. Proc Nat Acad Sci USA. 2007: 104(35); 1406814073.
  • 3
    WollertKC, MeyerGP, LotzJ, Ringes-Lichtenber S, Lippolt P, Breidenbach C, Fichter S, Korte T, Hornig B, Messinger D, et al . Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004: 364; 141148.
  • 4
    SchachingerV, ErbsS, ElsasserA, HaberboschW, HambrechtRainer, HolschermannH, YuJ, CortiR, MatheyDG, HammCQ, et al . Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med . 2006: 355(12); 12101221.
  • 5
    BolliR, ChughAR, D’AmarioD, LoughranJH, StoddardMF, IkramS, BeacheGM, WagnerSG, LeriA, HosodaT, et al . Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomized phase 1 trial. Lancet. 2011: 378(9806); 18471857.
  • 6
    HouD, YoussefEA, BrintonTJ, ZhangP, RogersP, PriceET, YeungAC, JohnstoneBH, YockPG, MarchKL. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation . 2005; 112: I150I156.
  • 7
    RotaM, KajsturaJ, HosodaT, BearziC, VitaleS, EspositoG, IaffaldanoG, Padin-IruegasME, GonzalezA, RizziR, et al . Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Nat Acad Sci USA. 2007: 104(45); 1778317788.
  • 8
    XuM, WaniM, DaiYS, WangJ, YanM, AyubA, AshrafM. Differentiation of bone marrow stromal cells into the cardiac phenotype requires intercellular communication with myocytes. Circulation. 2004: 110(17); 26582665.
  • 9
    TullochNL, MuskheliV, RazumovaMV, KorteSF, RegnierM, HauchKD, PabonL, ReineckeH, MurryCE. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res. 2011; 109(1): 4759.
  • 10
    SegersVFM, LeeRT. Biomaterials to enhance stem cell function in the heart. Circ Res. 2011; 109(8): 910922.
  • 11
    NgyuenPK, LanF, WangY, WuJC. Imaging: Guiding the clinical translation of cardiac stem cell therapy. Circ Res. 2011; 109: 962979.
  • 12
    LosordoDW, ValePR, SymesJF, DunningtonCH, EsakofDD, MayskyM, AshareAB, LathiK, IsnerJM. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation . 1998; 98(25): 28002804.
  • 13
    ZhangM, MalN, KiedrowskiM, ChackoM, AskariAT, PopovicZB, KocON, PennMS. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J . 2007; 21(12): 31973207.
  • 14
    GyongyosiM, DibN. Diagnostic and prognostic value of 3D NOGA mapping in ischemic heart disease. Nat Rev Cardiol . 2011; 8: 393404.
  • 15
    LosordoDW, ValePR, HendelRC, MillikenCE, FortuinFD, CummingsN, SchatzRA, AsaharaT, IsnerJM, KuntzRE. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation . 2002; 105(17): 20122018.
  • 16
    GyongyosiM, GlogarHD. Non-fluoroscopic catheter-based endocardial mapping and mapping-guided percutaneous transmyocardial revascularization. Austrian J Kardiol . 2001: 8; 503508.
  • 17
    WillersonJT, PerinEC, EllisSG, PepineCJ, HenryTD, ZhaoDX, LaiD, PennMS, ByrneBJ, SilvaG, et al . Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): rationale and design. Am Heart J . 2010; 160: 215223.
  • 18
    LosordoDW, HenryTD, DavidsonC, LeeJS, CostaMA, BassT, MendelsohnF, FortuinDF, PepineCJ, TraverseJH, et al . Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res. 2011; 209(4): 428436.
  • 19
    Schiller NB,   SP, CrawfordM, DeMariaA, DevereuxR, FeigenbaumH, GutgesellH, ReichekN, SahnD, SchnittgerI. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr . 1989; 5(2): 358367.
  • 20
    KuboH, MaruliesKB, PiacentinoVIII, GaughanJP, HouserSR. Patients with end-stage congestive heart failure treated with beta-adrenergic receptor antagonists have improved ventricular myocyte calcium regulatory protein abundance. Circulation. 2001; 104(9): 10121018.
  • 21
    HagemannD, KuschelM, KuramochiT, ZhuW, ChengH, XiaoRP. Frequency-encoding Thr17 phospholamban phosphorylation is independent of Ser16 phosphorylation in cardiac myocytes. J Biol Chem. 2000; 275: 2253222536.
  • 22
    PortJD, BristowMR. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. J Mol Cell Cardiol. 2001; 33: 887905.
  • 23
    Mundina-WeilenmannC, SaidM, VittoneL, FerreroP, MattiazziA. Phospholamban phosphorylation in ischemia-reperfused heart. Effect of pacing during ischemia and response to a beta-adrenergic challenge. Mol Cell Biochem. 2003; 252: 239246.
  • 24
    PetersonRT, SchreiberSL. Translation control: connecting mitogens and the ribosome. Curr Biol . 1998; 8(7): R248R250.
  • 25
    RotaM, BoniA, UrbanekK, Padin-IruegasE, KajsturaTJ, FioreG, KuboH, SonnenblickEH, MussoE, HouserSR. Nuclear targeting of Akt enhances ventricular function and myocyte contractility. Circulation Research. 2005; 97: 13321341.
  • 26
    Fernandes-AlnemriT, LitwackG, AlnemriES. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem. 1994; 269(49): 3076130764.
  • 27
    CommunalC, SinghK, PimentelDR, ColucciWS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the b-adrenergic pathway. Circulation . 1998; 98: 13291334.
  • 28
    ShizukudaY, ButtrickPM, GeenenDL, BorczukAC, KitsisRN, SonnenblickEH. b-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am J Physiol Heart Circ Physiol . 1998; 275: H961H968.
  • 29
    BraunwaldE. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival: should the paradigm be expanded? Circulation. 1989; 79: 441444.
  • 30
    PfefferMA, BraunwaldE. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation. 1990; 81: 11611172.